Einar M Sigurdsson Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

9/2008

Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Einar M Sigurdsson Research Topics

Disease

42	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 09/2002
22	Tauopathies 01/2022 - 10/2008
5	Cognitive Dysfunction 01/2019 - 10/2009
5	Dementia (Dementias) 01/2016 - 10/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 08/2007
5	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2007 - 07/2002
5	Amyloid Plaque 01/2006 - 09/2002
3	Neuroblastoma 04/2019 - 09/2008
2	Amyloidosis 11/2013 - 11/2006
2	Frontotemporal Dementia (Semantic Dementia) 08/2011 - 08/2007
2	Infections 08/2007 - 01/2003
2	Inflammation (Inflammations) 10/2006 - 11/2002
2	Scrapie 11/2003 - 01/2003
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 07/2021
1	Proteostasis Deficiencies 09/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Edema (Dropsy) 11/2013
1	Neuroinflammatory Diseases 11/2013
1	Encephalomyelitis (Myeloencephalitis) 11/2013
1	Prodromal Symptoms 11/2013
1	Memory Disorders (Memory Loss) 07/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2011
1	Parkinson Disease (Parkinson's Disease) 09/2011
1	Huntington Disease (Huntington's Disease) 09/2011
1	Weight Gain 02/2009
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 08/2007
1	Hemorrhage 11/2006
1	Meningoencephalitis 11/2006
1	Encephalitis (Encephalitis, Rasmussen) 02/2005
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2002

Drug/Important Bio-Agent (IBA)

15	Amyloid (Amyloid Fibrils)IBA 01/2021 - 09/2002
15	Amyloid beta-PeptidesIBA 11/2013 - 09/2002
12	tau Proteins (tau Protein)IBA 01/2022 - 10/2008
10	AntibodiesIBA 07/2021 - 11/2002
7	Peptides (Polypeptides)IBA 11/2013 - 09/2002
4	EpitopesIBA 01/2018 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 10/2010 - 01/2006
4	VaccinesIBA 02/2009 - 11/2002
4	Prion ProteinsIBA 11/2003 - 07/2002
2	PrionsIBA 08/2007 - 01/2003
1	Monoclonal AntibodiesIBA 01/2021
1	CalciumIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	LigandsIBA 01/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018
1	Islet Amyloid PolypeptideIBA 01/2016
1	Immunoglobulin G (IgG)IBA 04/2015
1	IronIBA 11/2013
1	ManganeseIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	SynucleinsIBA 09/2011
1	Superoxide DismutaseIBA 09/2011
1	Protein AggregatesIBA 12/2010
1	Memantine (Namenda)FDA Link 09/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2008
1	N-Methylaspartate (NMDA)IBA 09/2008
1	saponin QA-21V1 (QS21)IBA 11/2006
1	Insulysin (Insulin-Degrading Enzyme)IBA 10/2006
1	Contrast MediaIBA 01/2005
1	CopperIBA 11/2003
1	Chelating AgentsIBA 11/2003
1	Penicillamine (Cuprimine)FDA Link 11/2003
1	GadoliniumIBA 11/2002

Therapy/Procedure

21	Immunotherapy 07/2021 - 01/2006
11	Therapeutics 01/2019 - 11/2002
1	Intravenous Injections 01/2021
1	Injections 02/2009